Unlock stock picks and a broker-level newsfeed that powers Wall Street.

TSXV - Delayed Quote CAD

Conavi Medical Corp. (CNVI.V)

0.3800
-0.0200
(-5.00%)
At close: May 7 at 3:18:46 PM EDT
Loading Chart for CNVI.V
  • Previous Close 0.4000
  • Open 0.4000
  • Bid 0.3750 x --
  • Ask 0.3900 x --
  • Day's Range 0.3750 - 0.4000
  • 52 Week Range 0.3600 - 1.5200
  • Volume 38,700
  • Avg. Volume 34,952
  • Market Cap (intraday) 16.815M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.

conavi.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: CNVI.V

View More

Performance Overview: CNVI.V

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CNVI.V
41.54%
S&P/TSX Composite index (^GSPTSE)
2.20%

1-Year Return

CNVI.V
69.60%
S&P/TSX Composite index (^GSPTSE)
12.88%

3-Year Return

CNVI.V
69.60%
S&P/TSX Composite index (^GSPTSE)
21.94%

5-Year Return

CNVI.V
69.60%
S&P/TSX Composite index (^GSPTSE)
69.62%

Compare To: CNVI.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNVI.V

View More

Valuation Measures

As of 5/7/2025
  • Market Cap

    16.82M

  • Enterprise Value

    31.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -98.23%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.16M

  • Net Income Avi to Common (ttm)

    -43.62M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    436k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -16.88M

Research Analysis: CNVI.V

View More

People Also Watch